Copyright
©The Author(s) 2025.
World J Clin Pediatr. Jun 9, 2025; 14(2): 104797
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.104797
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.104797
Table 3 Specific anti-microbial roles of some human milk oligosaccharides
HMO type | Key pathogens targeted | Mode of action |
2'-FL | Campylobacter jejuni, EPEC, Norovirus, RSV, Rotavirus | Anti-adhesive activity, inhibition of pathogen attachment to epithelial cells, by acting as a decoy receptor |
3-FL | EPEC, Pseudomonas aeruginosa, Salmonella enterica, and Norovirus (pathogens commonly encountered later in infancy) | The prebiotic effect promotes beneficial bacteria and blocks pathogen adhesion |
DFL | Escherichia coli, Campylobacter jejuni, Salmonella enterica, Helicobacter pylori | Anti-adhesive activity preventing pathogen attachment to epithelial cells; supports immune modulation and gut barrier function |
LNT | Entamoeba histolytica, GB. streptococcus, Vibrio cholera toxin | Neutralization of bacterial toxins and prevention of protozoal adhesion |
3'-SL | EPEC, Helicobacter pylori, Pseudomonas aeruginosa, Vibrio cholera toxin, RSV, Rotavirus | Blocking bacterial adhesion and neutralizing bacterial toxins |
6'-SL | EPEC, Helicobacter pylori, Pseudomonas aeruginosa, Influenza virus, Rotavirus | Inhibition of bacterial and viral adherence, especially in respiratory and gastrointestinal infections |
- Citation: Al-Beltagi M. Human milk oligosaccharide secretion dynamics during breastfeeding and its antimicrobial role: A systematic review. World J Clin Pediatr 2025; 14(2): 104797
- URL: https://www.wjgnet.com/2219-2808/full/v14/i2/104797.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i2.104797